[1]Nate;Sekine;Oda;Aoe;Nakai;Wada;Takeda;Yabana;Nagao[ChemicalandPharmaceuticalBulletin,1987,vol.35,#8,p.3253-3261]
[1]Patent:EP2857398,2015,A1
[1]Patent:WO2019/210828,2019,A1.Locationinpatent:Paragraph0203;0204
111953-46-9
1391417-03-0
74190-66-2
91564-44-2
118577-00-7
154777-21-6
103659-08-1 | 4-Thiazolidinecarboxylicacid, 2-methyl-3-nitroso- | AA007FTU | MFCD18382407
1542-34-3 | 3,5-Difluoro-4-iodoaniline | AA007G8L | MFCD07774190
32318-42-6 | 2-Hydroxy-5-(methylthio)benzoic acid | AA007GQ7 | MFCD00156978
3415-35-8 | 4-Methyl-3,4-dihydro-1h-1,4-benzodiazepine-2,5-dione | AA007H5R | MFCD00835345
15372-84-6 | 4-Benzoyl-1h-pyrrole-2-carboxylic acid | AA007HMK | MFCD03001199
153505-36-3 | 4-Bromo-5-fluoro-2-nitroaniline | AA007I5O | MFCD11101433
31748-44-4 | 1-Methyl-1H-indazole-3-carbonitrile | AA007ILG | MFCD09971307
893734-77-5 | Methyl 5-(4-fluorophenyl)nicotinate | AA007J5B | MFCD06802188
148315-69-9 | 1-(2-(3-Methoxyphenoxy)ethyl)piperazine | AA007JLY | MFCD03231418
298-00-0 | o,o-dimethyl o-(4-nitrophenyl) phosphorothioate | AA007K89 | MFCD00041813
1354018-21-5
27028-76-8
5408-57-1
521301-40-6
895803-44-8
133603-12-0